Back | Home Agenda

Download PDF

Track: Pharma Process

Fri 12

15:30h

Roundtable | Side Events Pharma Process

Resiliencia y competitividad industrial impulsadas por datos: casos de uso y hoja de ruta de madurez.

Alicia Tébar QbD PS Founder Moderator

Pol Salvadó Almirall Facility Plant Director Speaker

Francisco De Tierra Laboratorios HIPRA S.A. HIPRA Robotics Senior Engineer Speaker

Fernando Campos Martínez Sanofi IIoT Expert Speaker

2026-06-02 15:30 2026-06-02 16:30 Europe/Madrid Resiliencia y competitividad industrial impulsadas por datos: casos de uso y hoja de ruta de madurez. We will explore real implementation cases in the Pharma industry: Digital Twins, real-time process monitoring (CPV 4.0), and AI use in GMP-regulated environments, aimed at improving quality, flexibility, and sustainability. The session highlights the importance of clearly defining needs before selecting tools, co-creating with all stakeholders (creators and users) to ensure adoption and ROI. These cases will also be contrasted with plant and company digital maturity indexes, assessing current status, gaps, and preparations to become the plant of the future over the next decade. It will be an interactive space to discuss priorities, barriers, and practical implementation decisions. Industry Showcase

Tue 2

15:30h - 16:30h Industry Showcase Registration for the activity during Expoquimia accreditation

10:00h

Roundtable | Side Events Pharma Process

Pressure, complexity, speed and risk: the combination defining the pharma sector agenda in 2026

Isaac Serra Alamgro Qualipharma CSV Leader Speaker

Andrés Morales Fernández KPMG Associate Partner Speaker

Toni Haro García AG Solution Team Leader OT Security (Europe South) Speaker

#FarmaTech2026, #industrialcybersecurity, #NetPharmaHub, #pharmaprocess, #regulatorycompliance

2026-06-02 10:00 2026-06-02 11:45 Europe/Madrid Pressure, complexity, speed and risk: the combination defining the pharma sector agenda in 2026

The pharmaceutical sector and the chemical industry face a dual pressure in 2026: increasing regulatory demands and technological acceleration with growing risks. The common axis is data: its integration, traceability, and security determine organizations’ ability to adapt.

Regulatory developments (Annex 22, 11, Chapter IV and NIS2) no longer require only process validation, but also demonstrating control and data integrity at every stage, driving a new governance culture.

At the same time, OT/IT threats, ransomware, and data breaches put this very asset at risk: compromising its availability invalidates regulatory compliance and threatens business continuity.

Protecting data means, at the same time, protecting the business and ensuring compliance. In this Net-Pharma Hub session, we will share experiences and solutions to address this scenario.

International Meeting Point

Tue 2

10:00h - 11:45h International Meeting Point Public access

12:00h

Roundtable | Side Events Pharma Process

Digitalization and AI in pharmaceutical industrial sites — from discussion to action

Pol Salvadó Almirall Facility Plant Director Speaker

Nacho Llubiá Navarro ManageArt Managing Partner Host

Carlos Morrás Ruiz-Falcó Escorial Analytics / Universidad Pontificia ICAI- Comillas Managing partner / Master’s director. University professor. Moderator

Pau Cuadrado Agell Boehringer Ingelheim Digital Champion & MBR Designer Speaker

Asier Herrero Cinfa Head of Organization and Digitalization Speaker

#artificialintelligence, #digitalization, #industrialefficiency, #pharmaindustry

2026-06-02 12:00 2026-06-02 13:30 Europe/Madrid Digitalization and AI in pharmaceutical industrial sites — from discussion to action

The round table led by ManageArt will highlight in which areas of pharmaceutical industrial sites digitalization and artificial intelligence projects are being applied. It will provide an overview of where there are opportunities to implement digital projects, quantifying the savings achieved, in order to identify which areas present challenges and opportunities to improve site competitiveness, both from an effectiveness and efficiency perspective.

Topics related to projects will be discussed from the standpoint of their organization and implementation. Among other aspects, the criteria used for evaluating decisions on project implementation will be analyzed. Likewise, the critical aspects in the development and implementation of these projects will be discussed, including the involvement of key roles to ensure success, as well as the most common barriers in this type of initiatives.

Achieved returns will be shared, and sector-specific aspects will be addressed, such as validation of systems related to artificial intelligence, experiences in regulatory audits, and expectations regarding GMP Annex 22.

International Meeting Point

Tue 2

12:00h - 13:30h International Meeting Point Public access

REGISTER BEFORE 07.05.2023 TO GET A 50% DISCOUNT

Track: Pharma Process

Resiliencia y competitividad industrial impulsadas por datos: casos de uso y hoja de ruta de madurez.

Pressure, complexity, speed and risk: the combination defining the pharma sector agenda in 2026

Digitalization and AI in pharmaceutical industrial sites — from discussion to action

#EXPOQUIMIA2026

Make sure you don’t miss a thing!